Synapedia is an independent knowledge project about psychoactive substances and harm reduction. If the platform helps you learn something new, you can support its development.
Every bit helps keep the project alive.
Substance Comparison
Benzodiazepine and GHB are both classified as Depressiva. Available data suggests they share activity at GABA-A. Benzodiazepine is commonly associated with a moderate risk profile compared to GHB.
Both substances belong to the Depressiva class, making this a common comparison for understanding differences within the same pharmacological family.
| Benzodiazepine | GHB | |
|---|---|---|
| Class | Depressiva | Depressiva |
| Risk Level | moderate | high |
| Mechanisms | Positive allosterische Modulation am GABA-A-Rezeptor | GABA-B-Agonist, GHB-Rezeptor-Agonist |
| Receptors | GABA-A | GABA-A, GABA-B |
| Effects | — | Euphorie und Hochgefühl (niedrige Dosen), Enthemmung und Gesprächigkeit, Gesteigerte Libido und Empathie, Entspannung und Sedierung, Anterograde Amnesie (mittlere bis hohe Dosen) |
| Evidence | — |
GHB wirkt als Agonist an GABA-B-Rezeptoren und GHB-Rezeptoren, was zu sedierenden und euphorisierenden Effekten führt.
No harm reduction data available
Safer-use data available on substance page
Evidence: not assessed · Sources: 2
Evidence: unknown · Sources: 2
| unknown |